Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine/docetaxel with or without epoetin beta in metastatic breast cancer with anemia
2006-000137-35Phase 4Terminated
- Sponsor
- Roche
- Start
- Feb 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of epoetin beta in breast cancer and anaemia (2 arms), sponsored by Roche. Primary endpoints: Objective response to treatment and Time to disease progression. Started Feb 2006; status: terminated.
02
Drugs
epoetin beta
03
Conditions
breast canceranaemia
Beyond the preview
Go deeper on 2006-000137-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000137-35.